Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
stomach | 100% | 5456.60 | 359 / 359 | 100% | 60.59 | 285 / 286 |
skin | 100% | 2669.11 | 1806 / 1809 | 99% | 144.02 | 468 / 472 |
intestine | 100% | 3154.74 | 966 / 966 | 98% | 69.28 | 518 / 527 |
esophagus | 100% | 3314.53 | 1445 / 1445 | 98% | 45.98 | 179 / 183 |
prostate | 100% | 6262.90 | 245 / 245 | 97% | 59.32 | 487 / 502 |
pancreas | 100% | 4128.14 | 328 / 328 | 96% | 67.67 | 171 / 178 |
uterus | 100% | 3701.12 | 170 / 170 | 93% | 37.65 | 428 / 459 |
bladder | 100% | 3509.71 | 21 / 21 | 91% | 36.07 | 459 / 504 |
kidney | 100% | 3605.94 | 89 / 89 | 87% | 43.97 | 782 / 901 |
lung | 99% | 2363.12 | 575 / 578 | 87% | 35.80 | 1008 / 1155 |
breast | 100% | 4352.64 | 459 / 459 | 86% | 32.57 | 957 / 1118 |
ovary | 88% | 1358.04 | 158 / 180 | 97% | 48.03 | 417 / 430 |
thymus | 100% | 2856.37 | 652 / 653 | 83% | 18.79 | 502 / 605 |
adipose | 100% | 4502.51 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 7160.47 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 81.99 | 80 / 80 |
spleen | 100% | 2406.91 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 12.15 | 1 / 1 |
tonsil | 0% | 0 | 0 / 0 | 93% | 25.14 | 42 / 45 |
heart | 87% | 1810.85 | 746 / 861 | 0% | 0 | 0 / 0 |
adrenal gland | 60% | 567.36 | 155 / 258 | 8% | 1.39 | 18 / 230 |
lymph node | 0% | 0 | 0 / 0 | 52% | 9.23 | 15 / 29 |
liver | 19% | 332.11 | 42 / 226 | 30% | 17.00 | 120 / 406 |
muscle | 48% | 528.03 | 383 / 803 | 0% | 0 | 0 / 0 |
brain | 22% | 335.21 | 578 / 2642 | 19% | 3.42 | 133 / 705 |
peripheral blood | 5% | 50.03 | 45 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0016486 | Biological process | peptide hormone processing |
GO_0016485 | Biological process | protein processing |
GO_0042985 | Biological process | negative regulation of amyloid precursor protein biosynthetic process |
GO_0032438 | Biological process | melanosome organization |
GO_0050435 | Biological process | amyloid-beta metabolic process |
GO_0006508 | Biological process | proteolysis |
GO_0042593 | Biological process | glucose homeostasis |
GO_0006509 | Biological process | membrane protein ectodomain proteolysis |
GO_0005802 | Cellular component | trans-Golgi network |
GO_0033162 | Cellular component | melanosome membrane |
GO_0005768 | Cellular component | endosome |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0004190 | Molecular function | aspartic-type endopeptidase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | BACE2 |
Protein name | Beta-secretase 2 (EC 3.4.23.45) (Aspartic-like protease 56 kDa) (Aspartyl protease 1) (ASP1) (Asp 1) (Beta-site amyloid precursor protein cleaving enzyme 2) (Beta-site APP cleaving enzyme 2) (Down region aspartic protease) (DRAP) (Memapsin-1) (Membrane-associated aspartic protease 1) (Theta-secretase) |
Synonyms | UNQ418/PRO852 ASP21 ALP56 AEPLC CDA13 |
Description | FUNCTION: Responsible for the proteolytic processing of the amyloid precursor protein (APP). Cleaves APP, between residues 690 and 691, leading to the generation and extracellular release of beta-cleaved soluble APP, and a corresponding cell-associated C-terminal fragment which is later released by gamma-secretase. It has also been shown that it can cleave APP between residues 671 and 672 . Involved in the proteolytic shedding of PMEL at early stages of melanosome biogenesis. Cleaves PMEL within the M-beta fragment to release the amyloidogenic PMEL luminal fragment containing M-alpha and a small portion of M-beta N-terminus. This is a prerequisite step for subsequent processing and assembly of PMEL fibrils into amyloid sheets . Responsible also for the proteolytic processing of CLTRN in pancreatic beta cells . . |
Accessions | ENST00000347667.5 [Q9Y5Z0-2] ENST00000330333.11 [Q9Y5Z0-1] ENST00000328735.10 [Q9Y5Z0-3] Q9Y5Z0 |